CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC)

CUSIP: N2451R105

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Shares, par value (euro)0.12 per share
Shares outstanding
22,421,536
Total 13F shares
7,148,145
Share change
-1,299,788
Total reported value
$56,407,292
Put/Call ratio
85%
Price per share
$7.88
Number of holders
76
Value change
-$15,368,475
Number of buys
35
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP N2451R105?
CUSIP N2451R105 identifies CVAC - CureVac N.V. - Common Shares, par value (euro)0.12 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q3 2022

As of 30 Sep 2022, CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,148,145 shares. The largest 10 holders included Bill & Melinda Gates Foundation, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, NORGES BANK, GOLDMAN SACHS GROUP INC, MARSHALL WACE, LLP, MORGAN STANLEY, Man Group plc, CREDIT SUISSE AG/, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 76 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.